An 8-Year Survivor after Three-Time Hepatectomies for Metachronous Pancreatic Adenocarcinoma Liver Metastases
Multidisciplinary treatment, including chemotherapy, resection, and RFA, may increase survival time in selected PDAC patients.
Authors
- Toshiro Masuda (ORCID: https://orcid.org/0000-0003-4306-4277)
- Masahiko Hirota (ORCID: https://orcid.org/0000-0001-7651-5375)
- hiroki SUGITA
- Toru Beppu (ORCID: https://orcid.org/0000-0001-9046-0454)
- Takeshi Morinaga (ORCID: https://orcid.org/0000-0002-0523-9067)
- Hirohisa Okabe
- Hidetoshi Nitta
- Ryoichi Kurano
- Naoki Umezaki
Institutions
- Kumamoto Medical Center (JP)
Publication Details
- Journal
- Surgical Case Reports
- Published
- 2026-01-01
- DOI
- https://doi.org/10.70352/scrj.cr.25-0242
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00